Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum”

568 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 568 results

Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Study completedNCT02020707
What this trial is testing

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

Who this might be right for
Cervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more
Mayo Clinic 43
Not applicableStudy completedNCT01832415
What this trial is testing

First Line Ovarian Cancer Treatment - Cohort Study

Who this might be right for
Epithelial Ovarian Cancer
ARCAGY/ GINECO GROUP 500
Testing effectiveness (Phase 2)Study completedNCT06087289
What this trial is testing

Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Novakand Pharma AB 18
Large-scale testing (Phase 3)Study completedNCT00262990
What this trial is testing

Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms
Novartis Pharmaceuticals 829
Testing effectiveness (Phase 2)Study completedNCT02272790
What this trial is testing

Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
AstraZeneca 95
Testing effectiveness (Phase 2)Ended earlyNCT00331422
What this trial is testing

Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Masonic Cancer Center, University of Minnesota 7
Not applicableEnded earlyNCT01744821
What this trial is testing

Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Northwestern University 7
Testing effectiveness (Phase 2)UnknownNCT01100372
What this trial is testing

Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Medical University Innsbruck 154
Early research (Phase 1)Study completedNCT01314105
What this trial is testing

BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer

Who this might be right for
Ovarian NeoplasmsPeritoneal Neoplasms
Boehringer Ingelheim 19
Testing effectiveness (Phase 2)Ended earlyNCT02834975
What this trial is testing

Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).

Who this might be right for
Fallopian Tube CancerPeritoneum CancerEpithelial Ovarian Cancer
University of Miami 26
Testing effectiveness (Phase 2)Ended earlyNCT02012192
What this trial is testing

GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Medical University Innsbruck 133
Not applicableWithdrawnNCT04826029
What this trial is testing

Impact of Systematic Imaging for Follow up of Patients With Ovarian, Fallopian Tube or Primary Peritoneum Cancer

Who this might be right for
Advanced Stage Serous Epithelial Cancer of the OvaryAdvanced Stage Cancer of TubesAdvanced Stage Cancer of Peritoneum
Assistance Publique - Hôpitaux de Paris
Early research (Phase 1)Study completedNCT00045175
What this trial is testing

UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
University Health Network, Toronto 33
Testing effectiveness (Phase 2)Study completedNCT00436501
What this trial is testing

VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerMalignant Tumor of PeritoneumRecurrent Ovarian Epithelial Cancer
National Cancer Institute (NCI) 58
Not applicableWithdrawnNCT04889495
What this trial is testing

A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer

Who this might be right for
Non-small Cell Lung CancerMetastatic Colorectal CancerMetastatic Breast Cancer+5 more
Pfizer
Testing effectiveness (Phase 2)Study completedNCT01974765
What this trial is testing

Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies

Who this might be right for
Advanced Epithelial OvarianRecurrent Epithelial OvarianFallopian Tube+1 more
Memorial Sloan Kettering Cancer Center 59
Early research (Phase 1)Ended earlyNCT02452775
What this trial is testing

Autologous OC-L Vaccine and Ovarian Cancer

Who this might be right for
Primary Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Abramson Cancer Center at Penn Medicine 3
Not applicableNot Yet RecruitingNCT07690332
What this trial is testing

A Real-world Study of Mirvetuximab Soravtansine (MIRV) in Ovarian Cancer Patients of Expression of Folate Receptor α（FRα）

Who this might be right for
Ovarian CancerFallopian Tube CancersPrimary Peritoneal Cancer
NING LI-GYN 400
Large-scale testing (Phase 3)Study completedNCT02311907
What this trial is testing

Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityNeuropathyNeurotoxicity Syndrome+13 more
Alliance for Clinical Trials in Oncology 195
Next Page